Concepedia

Michael O’Dwyer

MO

Statistics

Publications

71

Citations

7K

H-Index

38

Active since

2000

Affiliations

Ollscoil na Gaillimhe – University of Galway(Current)

University Hospital Galway

University of Alberta

Janssen (United States)

The University of Texas MD Anderson Cancer Center

Michael O’Dwyer is an author at Ollscoil na Gaillimhe – University of Galway specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2000–2025

71

Publications

71

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Thierry Façon, Shaji Kumar, Torben Plesner et al. · New England Journal of Medicine · 2019 · 987 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

Thierry Façon, Shaji Kumar, Torben Plesner et al. · The Lancet Oncology · 2021 · 363 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes

Dan Zhang, Rui Guo, Lei Lei et al. · Journal of Leukocyte Biology · 2020 · 306 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia

Ronan Swords, Kevin R. Kelly, Peter G. Smith et al. · Blood · 2010 · 277 citations · Full text

Medicine, Oncology, Pharmacology +7

1–5 of 71